We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$50B
AUM Growth
+$1.17B
Cap. Flow
-$2.18B
Cap. Flow %
-4.37%
Top 10 Hldgs %
19.12%
Holding
2,694
New
394
Increased
928
Reduced
982
Closed
383

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$620M
2
SNOW icon
Snowflake
SNOW
+$450M
3
COR icon
Cencora
COR
+$403M
4
CVNA icon
Carvana
CVNA
+$320M
5
MSCI icon
MSCI
MSCI
+$318M

Sector Composition

Rank Sector Weight
1 Technology 25.56%
2 Financials 17.22%
3 Consumer Discretionary 12.2%
4 Healthcare 11.63%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBCAA icon
1901
Republic Bancorp
RBCAA
$1.97B
$364K ﹤0.01%
5,041
+100
+2% +$7.38K
LAND
1902
Gladstone Land Corp
LAND
$366M
$362K ﹤0.01%
39,500
+15,800
+67% +$149K
NPO icon
1903
Enpro
NPO
$6.63B
$362K ﹤0.01%
1,600
-200
-11% -$43.2K
LENZ
1904
LENZ Therapeutics
LENZ
$184M
$359K ﹤0.01%
+7,697
New +$283K
IBN icon
1905
ICICI Bank
IBN
$109B
$357K ﹤0.01%
11,800
-588,600
-98% -$19.2M
WRLD icon
1906
World Acceptance Corp
WRLD
$880M
$355K ﹤0.01%
2,100
-7,200
-77% -$1.21M
CCRN
1907
DELISTED
Cross Country Healthcare
CCRN
$355K ﹤0.01%
25,000
-300
-1% -$3.96K
DOLE icon
1908
Dole
DOLE
$1.35B
$355K ﹤0.01%
26,400
+10,600
+67% +$149K
INGM
1909
Ingram Micro Holding
INGM
$6.93B
$352K ﹤0.01%
+16,400
New +$333K
AKBA icon
1910
Akebia Therapeutics
AKBA
$341M
$349K ﹤0.01%
127,849
+4,800
+4% +$16K
ACHV icon
1911
Achieve Life Sciences
ACHV
$634M
$347K ﹤0.01%
+110,300
New +$303K
ANIK icon
1912
Anika Therapeutics
ANIK
$202M
$347K ﹤0.01%
36,883
+17,800
+93% +$170K
CCLD icon
1913
CareCloud
CCLD
$100M
$346K ﹤0.01%
107,800
-24,100
-18% -$69.8K
TNYA icon
1914
Tenaya Therapeutics
TNYA
$164M
$346K ﹤0.01%
213,500
+45,700
+27% +$46K
AQN icon
1915
Algonquin Power & Utilities
AQN
$4.68B
$346K ﹤0.01%
64,400
-77,700
-55% -$447K
ORLA
1916
Orla Mining
ORLA
$3.42B
$343K ﹤0.01%
31,800
-92,000
-74% -$986K
GILT icon
1917
Gilat Satellite Networks
GILT
$812M
$342K ﹤0.01%
26,300
-47,500
-64% -$436K
ONL
1918
Orion Office REIT
ONL
$148M
$342K ﹤0.01%
126,700
+92,300
+268% +$247K
AARD
1919
Aardvark Therapeutics
AARD
$140M
$342K ﹤0.01%
+25,700
New +$290K
UFI icon
1920
UNIFI
UFI
$121M
$341K ﹤0.01%
71,548
-1,500
-2% -$6.92K
ANTX icon
1921
AN2 Therapeutics
ANTX
$169M
$340K ﹤0.01%
267,900
-1,700
-0.6% -$1.94K
VERX icon
1922
Vertex
VERX
$2.14B
$337K ﹤0.01%
13,600
-4,600
-25% -$133K
MITK icon
1923
Mitek Systems
MITK
$758M
$337K ﹤0.01%
34,500
+3,700
+12% +$36.4K
FLR icon
1924
Fluor
FLR
$6.89B
$337K ﹤0.01%
+8,000
New +$368K
HTT
1925
High Templar Tech Ltd
HTT
$377M
$336K ﹤0.01%
78,684
+17,000
+28% +$68.2K

Similar funds

Two Sigma Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, Two Sigma Advisers held 2,694 positions worth $50B, up 2.4% from $48.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Two Sigma Advisers withdrew a net $2.18B in Q3 2025, closing 383 positions and reducing 982 holdings. Its most notable exit was Aon, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Two Sigma Advisers opened a new position in TJX Companies worth $209M.

  • Two Sigma Advisers's largest Q3 2025 buy was TJX Companies: 1,447,098 shares worth $209M.
  • Two Sigma Advisers added most to JPMorgan Chase in Q3 2025, an estimated $629M increase.
  • Two Sigma Advisers's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $620M.
  • Two Sigma Advisers fully exited Aon in Q3 2025, selling an estimated $258M.
  • Two Sigma Advisers's ten largest holdings make up 19% of its $50B portfolio in Q3 2025.
  • Two Sigma Advisers opened 394 new positions and closed 383 in Q3 2025.
  • Two Sigma Advisers's portfolio value rose 2.4% quarter-over-quarter to $50B.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.